Follow on Google News News By Tag Industry News * Pharmaceutical * More Industries... News By Location Country(s) Industry News
Follow on Google News | Crystal Pharmatech Launched China’s First Training Course on PolymorphismCrystal Pharmatech Co.,Ltd researchers held an incredibly successful two-day training program on polymorphism and solid state characterization at Suzhou Industrial Park, China March 24th and 25th.
By: Crystal Pharmatech Polymorphism in drug development can significantly impact: bioavailability; Sessions focused on illuminating the participants on the impact of polymorphism and solid state properties in pharmaceutical development. Real “case studies”, characterization tools, and problem solving skills were discussed in-depth. Topics included: • • • • • • • • Researchers came out of the session with a new outlook on how understanding polymorphism and solid state properties in drug substance and drug product can significantly enhance the quality of their processes and product. “It was incredible to see the powerful solid state characterization concepts and tools available to us that can drive robustness and productivity in our processes” explains Dr. Yen from Tai-Gen Biotechnology, a top innovator pharmaceutical company in Taiwan. “A basic understanding of solid state properties and polymorphism is critical to API development and will definitely enhance the overall quality of our business.” A post meeting survey indicated that 97% of the attendees would either attend another Crystal Pharmatech training or recommend it to their colleagues. Additionally, 93% of the attendees mentioned that they were very satisfied with the training program. “The overwhelmingly positive response to the training was well beyond our highest expectations” One of the missions of Crystal Pharmatech Co., Ltd is to aid China based pharma companies in "catching up" with western pharma companies in discovery and development of innovative drugs. We believe that our training and experience will be critical to this mission and will continue to hold these training sessions while response remains positive. Crystal Pharmatech Co., Ltd is the first technology-driven solid state research CRO based in China. Crystal Pharmatech researchers have combined greater than 40 years experience in top-tier pharmaceutical companies focusing on solid state API and drug product development issues. Whether you are a top-tier innovator company or a pre-emerging biotech, Crystal Pharmatech can handle all of your solid-state property needs. It offers a full range of services from being the solid state characterization arm of your company to consultation or training on a specific issue. For more information, visit: http://www.crystalpharmatech.com/ # # # Crystal Pharmatech is a technology-driven CRO that focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. Our scientists have many years of experience in the pharmaceutical industry and are leading experts in the field of solid state characterization and API phase issues. Creative, customer focused solutions at the most competitive prices is our goal. Our data and interpretation will be of impeccable quality. Our services are focused on the specialized field of solid state information for active pharmaceutical ingredients and formulations. We will help our clients to discover and select the optimal solid phase for development as well as aid in developing the best formulation based on solid, scientific understanding. We are providing our clients a complete and satisfactory solution to the problem they face instead of merely running experiments and collecting data. End
Account Email Address Disclaimer Report Abuse Page Updated Last on: Mar 31, 2011
|
|